AI assistant
Medpace Holdings, Inc. — Director's Dealing 2021
Jul 12, 2021
30442_dirs_2021-07-12_edba8861-9a48-48f8-8260-7c9d2382683b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-07-08
Reporting Person: Medpace Investors, LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-08 | Common Stock | S | 3951 | $180.18 | Disposed | 6212325 | Direct |
| 2021-07-09 | Common Stock | S | 12597 | $183.34 | Disposed | 6199728 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $180.72. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.595 to $184.98. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.